Emerging infectious diseases · 2015
Risk factors for death from invasive pneumococcal disease, Europe, 2010.
Историческая статьяСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Navarro-Torné Adoración, Dias Joana Gomes, Hruba Frantiska, Lopalco Pier Luigi, Pastore-Celentano Lucia, Gauci Andrew J Amato, Invasive Pneumococcal Disease Study Group
Аннотация
We studied the possible association between patient age and sex, clinical presentation, Streptococcus pneumoniae serotype, antimicrobial resistance, and death in invasive pneumococcal disease cases reported by 17 European countries during 2010. The study sample comprised 2,921 patients, of whom 56.8% were men and 38.2% were >65 years of age. Meningitis occurred in 18.5% of cases. Death was reported in 264 (9.0%) cases. Older age, meningitis, and nonsusceptibility to penicillin were significantly associated with death. Non-pneumococcal conjugate vaccine (PCV) serotypes among children <5 years of age and 7-valent PCV serotypes among persons 5-64 years of age were associated with increased risk for death; among adults >65 years of age, risk did not differ by serotype. These findings highlight differences in case-fatality rates between serotypes and age; thus, continued epidemiologic surveillance across all ages is crucial to monitor the long-term effects of PCVs.
Предметные рубрики MeSH
AdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsChildChild, PreschoolEuropeFemaleHistory, 21st CenturyHumansIncidenceInfantMaleMicrobial Sensitivity TestsMiddle AgedMortalityPneumococcal InfectionsPneumococcal VaccinesPopulation SurveillanceRisk FactorsSerogroupStreptococcus pneumoniaeYoung Adult